Axsome at a four-month high as Truist raises target on deal to acquire sleep therapy - Seeking Alpha

Retrieved on: 2022-03-30 05:12:36

Tags for this article:

Sleep disorders

Psychoactive drugs

Branches of biology

Drugs

Solriamfetol

Excessive daytime sleepiness

Narcolepsy

Bupropion/dextromethorphan

Obstructive sleep apnea

Click the tags to see associated articles and topics

Axsome at a four-month high as Truist raises target on deal to acquire sleep therapy - Seeking Alpha. View article details on HISWAI: https://seekingalpha.com/news/3818577-axsome-climbs-as-truist-raises-target-on-acquisition-of-sleep-therapy

Excerpt

Sunosi, indicated to improve wakefulness in adults with excessive daytime sleepiness (EDS) due to narcolepsy or obstructive sleep apnea, ...

Article found on: seekingalpha.com

View Original Article